Skip to main content
Article thumbnail
Location of Repository

Biodegradable Polydepsipeptides

By Yakai Feng and Jintang Guo


This paper reviews the synthesis, characterization, biodegradation and usage of bioresorbable polymers based on polydepsipeptides. The ring-opening polymerization of morpholine-2,5-dione derivatives using organic Sn and enzyme lipase is discussed. The dependence of the macroscopic properties of the block copolymers on their structure is also presented. Bioresorbable polymers based on polydepsipeptides could be used as biomaterials in drug controlled release, tissue engineering scaffolding and shape-memory materials

Topics: Review
Publisher: Molecular Diversity Preservation International (MDPI)
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1982). 45, Homo- and copolymerizations of 3-methylmorpholine-2,5-dione initiated with a cyclic tin alkoxide.
    2. (2008). A biodegradable, immunoprotective, dual nanoporous capsule for cell-based therapies. Biomaterials
    3. (1990). A new biodegradable polydepsipeptide microsphere for application in drug delivery systems. Colloid Polym. Sci.
    4. (2001). A new photolabile linker for the photoactivation of carboxyl groups.
    5. (2008). A novel biodegradable copolymer for coronary artery stent: Preparation and its biocompatibility /in
    6. (2009). Accelerated degradation behaviour of poly(ε-caprolactone) via melt blending with poly(aspartic acid-colactide)
    7. (2004). Amido-modified polylactide for potential tissue engineering applications.
    8. (2003). Amino-terminated poly(ethylene glycol) as the initiator for the ring-opening polymerization of 3-methylmorpholine-2,5-dione.
    9. (1989). Bioabsorbable polydepsipeptides, their preparation and use.
    10. (2002). Biodegradable block copolymers with poly(ethylene oxide) and poly(glycolic acid-valine) blocks.
    11. (2001). Biodegradable copolymers based on poly(ethylene oxide), polylactide and polydepsipeptide sequences with functional groups. e-Polymers,
    12. (1999). Biodegradable cross-linked microspheres from poly(ε-caprolactone-coglycolic acid-co-L-serine) based polydepsipeptides.
    13. (1999). Biodegradable microspheres having reactive groups prepared from L-lactic acid-depsipeptide copolymers.
    14. Biodegradable multiblock copolymers based on oligodepsipeptides having shape-memory properties.
    15. (1997). Biodegradable polyester amides-synthesis and polymerization of morpholine-2,5-diones. Dissertation,
    16. Biodegradable polyesteramide.
    17. (1979). Biodegradable polymers for use in surgery-polyglycolic/polylactic acid homo and copolymers. Polymer
    18. (1989). Bioresorbable polymers for temporary therapeutic applications.
    19. (2007). Branched poly(lactide) synthesized by enzymatic polymerization: Effects of molecular branches and stereochemistry on enzymatic degradation and alkaline hydrolysis. Biomacromolecules
    20. (1984). Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule.
    21. (2003). Cell attachment and growth on films prepared from poly(depsipeptide-co-lactide) having various functional groups.
    22. (2004). Cell growth on the porous sponges prepared from poly(depsipeptide-co-lactide) having various functional groups.
    23. (2005). collaborative studies on biocatalytic generation of novel molecular architectures.
    24. (2003). Comment on “in vitro and in vivo evaluation of a technetium-99mlabeled cyclic RGD peptide as a specific marker of αVβ3 integrin for tumor imaging”. Bioconjugate Chem.
    25. (2006). Comments on the ring-opening polymerization of morpholine-2,5-dione derivatives by various metal catalysts and characterization of the products formed in the reactions involving
    26. (1995). Copolymerization and degradation of poly(lactic acid-co-lysine).
    27. (1998). Copolymerization of epsilon-caprolactone with (3S)-3-[(benzyloxycarbonyl)methyl]morpholine-2,5-dione and the C-13 NMR sequence analysis of the copolymer. Macromolecules
    28. (1992). Copolymerization of ε-caprolactone and morpholine-2,5-dione derivatives.
    29. (1986). Copolymers of D,L-lactic acid and glycine.
    30. (1983). Copolymers of p-dioxanone and 2,5-morpholinediones and surgical devices formed therefrom having accelerated absorption characteristics.
    31. (2008). Degradation of morpholine-2,5-dione derivative copolymer in
    32. (1977). Degradation rates of oral resorbable implants (polylactates and polyglycolates): Rate modification with changes in PLA/PGA copolymer ratios.
    33. (2006). Depsipeptide methodology for solid-phase peptide synthesis: Circumventing side reactions and development of an automated technique via depsidipeptide units.
    34. (2007). Depsipeptide synthesis, in Peptide characterization and application protocols, Series: Methods in Molecular Biology.
    35. (2004). Design of lactide copolymers as biomaterials.
    36. (2009). Drug releasing behavior of hybrid micelles containing polypeptide triblock copolymer. Biomaterials
    37. (1998). Electrogenerated chiral cationic glycine equivalents – Parts 2: Chiral 3-methoxy-2,5-morpholinediones from (S)-cz-hydroxy acids and dimethyl aminomalonate. Tetrahedron
    38. (2008). Enhanced cell affinity of poly(L-lactide) film by immobilizing phosphonized chitosan.
    39. (1986). Enzyme Work in Organic Solvents. Chemtech.
    40. (1999). Enzyme-catalyzed ring-opening polymerization of 3(S)-isopropyl-morpholine-2,5-dione. Macromol. Rapid Commun.
    41. (1996). Enzyme-catalyzed stereoelective ringopening polymerization of α-methyl-β-propiolactone. Macromolecules
    42. (2008). From material to tissue: Biomaterial development, scaffold fabrication, and tissue engineering.
    43. (2007). Functional polymer-bioconjugates as molecular LEGO ® bricks.
    44. (1994). Glycine/Glycolic acid based copolymers.
    45. (2008). Hydrogel nanoparticles in drug delivery.
    46. (1990). In vitro degradation of glycin/DL-lactic acid copolymers.
    47. (1989). In vivo and in vitro degradation of glycine/DL-lactic acid copolymers.
    48. (2003). Integrin avb3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr. Drug Targets
    49. Lipase catalyzed copolymerization of 3(S)-isopropyl-morpholine2,5-dione and D,L- lactide.
    50. (2005). Lipase catalyzed ring-opening polymerization of 6(S)-methylmorpholine-2,5-dione.
    51. (1998). Lipase-catalysed formation of macrocycles by ring-opening polymerisation of ε-caprolactone. Polymer
    52. (2008). Lipase-catalyzed polymerization of L-lactide in ionic liquids.
    53. (1999). Lipase-catalyzed ring-opening polymerization of 3(S)-isopropyl-morpholine-2,5-dione.
    54. (1999). Lipase-catalyzed ring-opening polymerization of lactones to polyesters and its mechanistic aspects.
    55. (2000). Lipase-catalyzed ring-opening polymerization of morpholine-2,5-dione derivatives: A novel route to the synthesis of poly(ester amide)s.
    56. (2008). Lipase-catalyzed synthesis of polylactic acid: An overview of the experimental aspects.
    57. (2001). Morpholine-2,5-diones — Their preparation and exploitation,
    58. (2008). Nanoparticles for gene transfer to human embryonic stem cell colonies. Nano Lett.
    59. (2008). Nanostructured biomaterials for regeneration.
    60. (1999). New biomaterial: Triblock copolymers of poly[3(S)-isobutylmorpholine-2,5-dione]-poly(ethylene oxide).
    61. (1972). Part XXI. Synthesis of some sequential macromolecular polypeptolides of L-leucine and L-2-hydroxy-4-methylpentanoic acid.
    62. (1996). Poly(L-lactic acid-co-amino acid) graft copolymers: A class of functional biodegradable biomaterials. In Hydrogels and Biodegradable Polymers for Bioapplications.
    63. (1988). Polydespeptides: Ring-opening polymerization of 3-methyl-2,5-morpholinedione, 3,6-dimethyl-2,5-morpholinedione and copolymerization thereof with D,Llactide.
    64. (2007). Polymer carriers for drug delivery in tissue engineering.
    65. (2008). Polymer-drug conjugates: Recent development in clinical oncology.
    66. (1998). Preliminary study of hydrogen bonding in (3S)-3-[(benzyloxycarbonyl)methyl]morpholine-2,5-dione and its effect on polymerization. Macromolecules
    67. (2002). Preparation of poly(L-lactide)-based microspheres having a cationic or anionic surface using biodegradable surfactants. Biomacromolecules
    68. (2004). Preparation of poly[DL-lactideco-glycolide]-based microspheres containing protein by use of amphiphilic diblock copolymers of depsipeptide and lactide having ionic pendant groups as biodegradable surfactants by W/O/W emulsion method. Polymer
    69. (1995). Process for the preparation of 3-, 6-substituted 2,5-morpholinediones,
    70. (2008). Recent developments in enzyme-catalyzed ring-opening polymerization.
    71. (1990). Sequential polydepsipeptides as biodegradable carriers for drug delivery systems.
    72. (1991). Sequential polydepsipeptides containing tripeptide sequences and alpha-hydroxy acids as biodegradable carriers.
    73. (2005). Shape-memory polymers as stimulisensitive implant materials.
    74. (2003). Surface hydrophilicity and enzymatic hydrolyzability of biodegradable polyesters: 1. Effects of alkaline treatment.
    75. (1998). Synthesis and characteristics of polydepsipeptide with pendant thiol groups.
    76. (2008). Synthesis and characterization of arginineglycine-aspartic peptides conjugated poly(lactic acid-co-L-lysine) diblock copolymer.
    77. (2006). Synthesis and characterization of inexpensive 3-N ε-benzyloxycarbonyl-L-lysyl-morpholine-2,5-dione.
    78. (2007). Synthesis and characterization of inexpensive 3-N ε-benzyloxycarbonyl-L-lysyl-morpholine-2,5-dione. Front.
    79. (1999). Synthesis and characterization of new ABA triblock copolymers with poly[3(S)-isobutyl-morpholine-2,5-dione] and polyethylene oxide blocks.
    80. (1999). Synthesis and characterization of new bioresorbable polyesteramides,
    81. Synthesis and characterization of new block copolymers with poly(ethylene oxide) and poly[3(S)-sec-butylmorpholine-2,5-dione] sequences.
    82. (1997). Synthesis and characterization of photocrosslinked polymers based on poly(L-lactic acid-co-L-aspartic acid). Macromolecules
    83. (1999). Synthesis and enzymatic degradation of optically active depsipeptide copolymers.
    84. (1997). Synthesis and enzymatic hydrolysis of lactic acid-depsipeptide copolymers with functionalized pendant groups.
    85. (1996). Synthesis and enzymatic hydrolysis of polydepsipeptides with functionalized pendant groups.
    86. (1997). Synthesis and modification of new biodegradable copolymers: Serine/glycolic acid based copolymers.
    87. (1993). Synthesis and RGD peptide modification of a new biodegradable copolymer: Poly(lactic acid-co-lysine).
    88. (2002). Synthesis of biodegradable amphiphilic AB-Type diblock copolymers of lactide and depsipeptide with pendant reactive groups.
    89. (1992). Synthesis of biodegradable polyesteramides with pendant functional groups.
    90. (1993). Synthesis of poly[(glycolic acid)-alt-(Laspartic acid)] and its biodegradation behavior in vitro.
    91. (2002). Synthesis of poly[(lactic acid)-alt- or co-((S)-aspartic acid)] from (3S, 6R,S)-3-[(benzyloxycarbonyl)methyl]-6-methylmorpholine-2,5-dione.
    92. (1985). Synthesis of poly[oxyethylidenecarbonylimino(2-oxoethylene)] [poly(glycine-D,L-lactic acid)] by ring opening polymerization.
    93. (1985). Synthesis of polydepsipeptides: Ring-opening polymerization of 6-isopropylmorpholine-2,5-dione and 6-isopropyl-4-methylmorpholine-2,5-dione.
    94. (2000). Synthesis of polymer network scaffolds and microspheres based on poly(ε-caprolactone-co-glycolic acid-co-L-serine).
    95. (2005). Synthesis of sequential polydepsipeptide microspheres as a controlled drug delivery system.
    96. (1987). Synthesis of sequential polydepsipeptides involving depsipeptide formation by the 2-nitrophenylsulphenyl N-carboxy α-amino acid anhydride (Nps–NCA)
    97. (2004). Synthesis of sequential polydepsipeptides utilizing a new approach for the synthesis of depsipeptides. Biopolymers
    98. (1982). Synthesis of sequential polymers containing some amino acids having polar side chains and (S)-lactic acid. Macromolecules
    99. (1978). Synthesis of sequential polymers containing varying ratios of L-alanine and L-lactic acid. Macromolecules
    100. (1975). Synthesis of the alternating polydepsipeptides poly(Ala-Lac) and poly(Val-Lac).
    101. Synthesis, self-assembly in water, and cytotoxicity of MPEG-block-PLLA/DX conjugates.
    102. (2000). Synthetic pathways to polydepsipeptides.
    103. (2007). Synthetic polypeptides for biomedical applications.
    104. (1943). The resolution and rates of hydrolysis of d,l-α-bromopropionic acid and its glycine derivatives.
    105. (2006). The synthesis and biodegradability of poly(lactide-random-depsipeptide)-PEG-poly(lactide-random-depsipeptide) ABA-type triblock copolymers.
    106. (1993). The use of enzymes in polymer synthesis.
    107. (2007). thermoresponsive, and biodegradable: Simple preparation of “all-in-one” biorelevant polymers. Macromolecules
    108. (2005). Thermosensitive biodegradable polydepsipeptide.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.